A new Kingston trial is improving the outcomes for stage 4 breast cancer patients using blood tests to cut down the time it takes to monitor the effectiveness of treatment.
Blood Tests
New blood tests cut down time to monitor advanced breast cancer treatment
You are viewing an Accelerated Mobile Webpage.
View Original Article